Sigma-Aldrich Bcr-Abl Inhibitor III, GNF-5, The Bcr-Abl Inhibitor III, GNF-5 Controls The Biological Activity Of Bcr-Abl. This Small Molecule/Inhibitor Is Primarily 10 Mg
Sigma-Aldrich -Secretase Inhibitor IV, CAS 797035-11-1, -Secretase Inhibitor IV, CAS 797035-11-1, Is A Cell-Permeable Inhibitor That Binds To BACE-1 Active Site A 1 Mg
Sigma-Aldrich -Secretase Inhibitor XX, CAS 209984-56-5, This -Secretase Inhibitor, CAS 209984-56-5, Is A Cell-Permeable Dibenzazepine Compound That Lowers Both Br 500 Ug
Sigma-Aldrich -Secretase Inhibitor IV, CAS 797035-11-1, -Secretase Inhibitor IV, CAS 797035-11-1, Is A Cell-Permeable Inhibitor That Binds To BACE-1 Active Site A 1 Mg
Sigma-Aldrich -Secretase Inhibitor XX, CAS 209984-56-5, This -Secretase Inhibitor, CAS 209984-56-5, Is A Cell-Permeable Dibenzazepine Compound That Lowers Both Br 500 Ug
Sigma-Aldrich Bcr-Abl Inhibitor III, GNF-5, The Bcr-Abl Inhibitor III, GNF-5 Controls The Biological Activity Of Bcr-Abl. This Small Molecule/Inhibitor Is Primarily 10 Mg
SponsoredAromatase Inhibitors Have Remained The Most Used Endocrine Therapy For Over 2 Decades. Aromatase Inhibitors May Limit Endocrine Therapy Efficacy On 1L. Time To Rethink Approach.